Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA. [electronic resource]
Producer: 20170629Description: 1504-14 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Cell Movement -- genetics
- Cell Transformation, Neoplastic -- drug effects
- Disease Models, Animal
- Docetaxel
- Drug Synergism
- Epithelial-Mesenchymal Transition -- genetics
- Gene Knockdown Techniques
- Humans
- I-kappa B Kinase -- genetics
- Male
- Mechanistic Target of Rapamycin Complex 1
- Mice
- Multiprotein Complexes -- metabolism
- NF-kappa B -- genetics
- Neoplastic Stem Cells -- drug effects
- Phosphorylation
- Prostatic Neoplasms -- genetics
- Protein Kinase Inhibitors -- pharmacology
- Proto-Oncogene Proteins c-akt -- metabolism
- Signal Transduction -- drug effects
- TOR Serine-Threonine Kinases -- metabolism
- Taxoids -- pharmacology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.